IL6 and COVID-19: Interleukin-6 (IL-6), a pro-inflammatory cytokine, has been extensively studied in the context of COVID-19 due to its role in the cytokine storm syndrome, which could be linked to the pathogenesis of changed headaches through systemic inflammation [27].